Destination Wealth Management Gilead Sciences, Inc. Transaction History

Destination Wealth Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $128,708 - $142,071	-2,059 Closed	0 $0
Q2 2019 Jul 19, 2019	SELL	$61.87 - $69.38 $280,147 - $314,152	-4,528 Reduced 68.74%	2,059 $139,000
Q1 2019 May 01, 2019	SELL	$62.53 - $70.05 $8,504 - $9,526	-136 Reduced 2.02%	6,587 $428,000
Q4 2018 Feb 05, 2019	SELL	$60.54 - $79.0 $101,888 - $132,957	-1,683 Reduced 20.02%	6,723 $421,000
Q3 2018 Nov 07, 2018	BUY	$71.28 - $78.92 $19,602 - $21,703	275 Added 3.38%	8,406 $649,000
Q2 2018 Jul 31, 2018	BUY	$64.88 - $75.68 $495,099 - $577,514	7,631 Added 1526.2%	8,131 $576,000
Q1 2018 Apr 05, 2018	BUY	$72.84 - $88.8 $36,420 - $44,400	500 New	500 $38,000
Q3 2017 Nov 09, 2017	SELL	$72.11 - $85.47 $256,495 - $304,016	-3,557 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	3,557	3,557 $252,000

1,942

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Destination Wealth Management with notifications on news.